Prospects in GSK-3 Signaling: From Cellular Regulation to Disease Therapy

Sara Arciniegas Ruiz; Ido Rippin; Hagit Eldar-Finkelman

doi:10.3390/cells11101618

Prospects in GSK-3 Signaling: From Cellular Regulation to Disease Therapy

Sara Arciniegas Ruiz, Ido Rippin, Hagit Eldar-Finkelman

Research output: Contribution to journal › Editorial

Original language	English
Article number	1618
Journal	Cells
Volume	11
Issue number	10
DOIs	https://doi.org/10.3390/cells11101618
State	Published - 2 May 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.3390/cells11101618

Cite this

@article{7a50b57360ef42268471b2fdd256fd87,

title = "Prospects in GSK-3 Signaling: From Cellular Regulation to Disease Therapy",

author = "Ruiz, \{Sara Arciniegas\} and Ido Rippin and Hagit Eldar-Finkelman",

note = "Funding Information: Funding: This research was funded by Israel Science Foundation \# 1843/17.",

year = "2022",

month = may,

day = "2",

doi = "10.3390/cells11101618",

language = "الإنجليزيّة",

volume = "11",

journal = "Cells",

issn = "2073-4409",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "10",

}

TY - JOUR

T1 - Prospects in GSK-3 Signaling

T2 - From Cellular Regulation to Disease Therapy

AU - Ruiz, Sara Arciniegas

AU - Rippin, Ido

AU - Eldar-Finkelman, Hagit

N1 - Funding Information: Funding: This research was funded by Israel Science Foundation # 1843/17.

PY - 2022/5/2

Y1 - 2022/5/2

UR - http://www.scopus.com/inward/record.url?scp=85129764683&partnerID=8YFLogxK

U2 - 10.3390/cells11101618

DO - 10.3390/cells11101618

M3 - كلمة العدد

C2 - 35626655

SN - 2073-4409

VL - 11

JO - Cells

JF - Cells

IS - 10

M1 - 1618

ER -

Prospects in GSK-3 Signaling: From Cellular Regulation to Disease Therapy

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this